David A. Reardon

Also affiliated with Center for Neuro-Oncology, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.530Author DataRank

Indexed papers

7in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 7 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients

Neuro-Oncology(2024)10.1093/neuonc/noae142

Top 37%

0.530DataRank

Top 37%14 citations

Jennifer Cotter, Mehdi Touat, Jayne Vogelzang, Cecília Almeida e Sousa, Will Pisano +24 more

Papers

Driven by 64 papers — median percentile 0. Top paper: “BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas”.

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

New England Journal of Medicine(2023)10.1056/nejmoa2213329

N/A

4.5DataRank · unranked

138 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Shervin Tabrizi +23 more

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Neuro-Oncology(2021)10.1093/neuonc/noab094

N/A

4.0DataRank · unranked

126 citations

Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid +18 more

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

Neuro-Oncology(2022)10.1093/neuonc/noac118

N/A

3.5DataRank · unranked

197 citations

Nayan Lamba, Manmeet S. Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K. Brastianos +20 more

Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial

Neuro-Oncology(2021)10.1093/neuonc/noab271

N/A

2.4DataRank · unranked

110 citations

Arnold B. Gelb, Clark C. Chen, Ganesh Rao, David A. Reardon, Patrick Y. Wen +19 more

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Journal of Clinical Oncology(2022)10.1200/jco.22.00996

N/A

2.3DataRank · unranked

159 citations

David A. Reardon, Ajay Abad, William T. Curry, Eric T. Wong, Sheila Figel +15 more

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005147

N/A

1.7DataRank · unranked

66 citations

Michael J. Pishvaian, Margaret K. Callahan, Amy Weise, Branimir I. Šikić, Osama E. Rahma +19 more

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Nature(2018)10.1038/s41586-018-0792-9

N/A

1.1DataRank · unranked

1412 citations

Jing Sun, Itay Tirosh, Nathan D. Mathewson, Shuqiang Li, Giacomo Oliveira +51 more

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

New England Journal of Medicine(2018)10.1056/nejmoa1805453

N/A

1.1DataRank · unranked

1335 citations

Peter A. Forsyth, Alain Algazi, Omid Hamid, F. Stephen Hodi, Stergios J. Moschos +17 more

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Cell(2021)10.1016/j.cell.2021.01.022

N/A

0.897DataRank · unranked

394 citations

Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez, Sascha Marx +38 more

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2500

N/A

0.835DataRank · unranked

261 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2291

N/A

0.776DataRank · unranked

176 citations

Prafulla C. Gokhale, Maria C. Speranza, Benjamin K. Eschle, Michael J. Poitras, Margaret K. Wilkens +18 more

Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response

Immunity(2022)10.1016/j.immuni.2022.09.002

N/A

0.747DataRank · unranked

144 citations

J. Bryan Iorgulescu, Shuqiang Li, Mehdi Borji, Irving Barrera, Vignesh Shanmugam +11 more

Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort

Nature Communications(2024)10.1038/s41467-024-54326-7

N/A

0.730DataRank · unranked

37 citations

Lu Sun, Gilbert C. Youssef, Raymond Y. Huang, Gang Li, Jiyoon Kim +31 more

Deep‐Learning Detection of Cancer Metastases to the Brain on MRI

Journal of Magnetic Resonance Imaging(2020)10.1002/jmri.27129

N/A

0.719DataRank · unranked

120 citations

Geoffrey S. Young, Huai Chen, Jing Li, Lei Qin, J Ricardo McFaline-Figueroa +5 more

Glioblastoma as an age-related neurological disorder in adults

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab125

N/A

0.705DataRank · unranked

109 citations

Erik Ladomersky, Andreas Mozny, Masha Kocherginsky, Kaitlyn O’Shea, Zachary Z. Reinstein +25 more

Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses

Scientific Reports(2020)10.1038/s41598-020-61736-2

N/A

0.568DataRank · unranked

43 citations

Hirotaka Ito, Carmela Passaro, Mykola Zdioruk, Ahmad Bakur Mahmoud, Korneel Grauwet +8 more

A Neuroradiologist’s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults

American Journal of Neuroradiology(2024)10.3174/ajnr.a8396

N/A

0.533DataRank · unranked

34 citations

Francesco Sanvito, Timothy F. Cloughesy, Raymond Y. Huang, Javier Villanueva-Meyer, Whitney B. Pope +21 more

A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients

Neuro-Oncology(2024)10.1093/neuonc/noae142

Top 37%

0.530DataRank

Top 37%14 citations

Jennifer Cotter, Mehdi Touat, Jayne Vogelzang, Cecília Almeida e Sousa, Will Pisano +24 more

Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2000

N/A

0.457DataRank · unranked

20 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Michael W. Ruff +15 more

ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-21-3521

N/A

0.449DataRank · unranked

19 citations

Ross Giglio, Maya Srikanth Graham, Guadalupe Garcia, Seth Malinowski, Jared K. Woods +41 more

Investigative needle core biopsies support multimodal deep-data generation in glioblastoma

Nature Communications(2025)10.1038/s41467-025-58452-8

N/A

0.442DataRank · unranked

18 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +71 more

First-in-human CAN-3110 (ICP-34.5 expressing HSV-1 oncolytic virus) in patients with recurrent high-grade glioma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2009

N/A

0.419DataRank · unranked

7 citations

Isaac H. Solomon, Hiroshi Nakashima, Sean Lawler, Daniel Triggs, Abigail Zhang +15 more

Impact of Higher Cell-Free DNA Yields on Liquid Biopsy Testing in Glioblastoma Patients

Clinical Chemistry(2025)10.1093/clinchem/hvae178

N/A

0.385DataRank · unranked

12 citations

Timothy Blewett, Kan Xiong, Andjela Crnjac, Ruolin Liu, Sainetra Sridhar +9 more

Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2005

N/A

0.373DataRank · unranked

11 citations

Kristen A. Batich, Duane A. Mitchell, James E. Herndon, Gloria Broadwater, Patrick Healy +15 more

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae202

N/A

0.345DataRank · unranked

9 citations

Adam L. Cohen, Midori Eckenstein, Randy L. Jensen, Lindsay Burt, Karen L. Salzman +18 more

[18F]F-AraG imaging reveals association between neuroinflammation and brown- and bone marrow adipose tissue

Communications Biology(2024)10.1038/s42003-024-06494-x

N/A

0.312DataRank · unranked

7 citations

Caroline Guglielmetti, Timothy J. Henrich, John C. Yoon, Prafulla C. Gokhale, David A. Reardon +17 more

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma

Neuro-Oncology(2025)10.1093/neuonc/noaf287

N/A

0.241DataRank · unranked

4 citations

Elisa Aquilanti, Julie J. Miller, Zhou Lan, Aleksandra B Lasica, Isabel Arrillaga‐Romany +20 more

Estimated clinical efficacy and radiographic response characteristics of PD1 inhibition in newly diagnosed and recurrent glioblastoma in clinical practice: A report from the iRANO Working Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2521

N/A

0.241DataRank · unranked

4 citations

Raymond Y. Huang, Javier Villanueva‐Meyer, Mary Jane Lim-Fat, Elizabeth George, Bryan Iorgulescu +13 more

Evaluation of GM-CSF and AS01B adjuvants in a phase I/IIa trial of a therapeutic CMV vaccine (VBI-1901) against recurrent glioblastoma (GBM).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2047

N/A

0.241DataRank · unranked

4 citations

David A. Reardon, Deborah Forst, Eudocia Q. Lee, Fábio M. Iwamoto, Francisco Díaz‐Mitoma +3 more

Auto-segmentation of Adult-Type Diffuse Gliomas: Comparison of Transfer Learning-Based Convolutional Neural Network Model vs. Radiologists

Journal of Imaging Informatics in Medicine(2024)10.1007/s10278-024-01044-7

N/A

0DataRank · unranked

9 citations

Ji‐Soo Kim, Clifford Lindsay, Xin Chen, Jing Li, J. Bryan Iorgulescu +6 more

ATIM-32. PERSONALIZED NEOANTIGEN-TARGETING VACCINE GENERATES ROBUST SYSTEMIC AND INTRATUMORAL T CELL RESPONSES IN GLIOBLASTOMA (GBM) PATIENTS

Neuro-Oncology(2018)10.1093/neuonc/noy148.027

N/A

0DataRank · unranked

0 citations

Itay Tirosh, Annabelle Anandappa, Jing Sun, Chang‐Jiun Wu, Evisa Gjini +21 more

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Neuro-Oncology(2025)10.1093/neuonc/noaf118

N/A

0DataRank · unranked

8 citations

Michael A. Vogelbaum, Timothy F. Cloughesy, Norbert Galldiks, Nathalie L. Albert, Joerg-Christian Tonn +30 more

Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy

Cancer Imaging(2025)10.1186/s40644-024-00818-0

N/A

0DataRank · unranked

7 citations

Clifford Lindsay, Chenxi Zhang, Ji‐Soo Kim, Xin Chen, Jing Li +5 more

Seizure characteristics and outcomes in patients with pleomorphic xanthoastrocytoma

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf134

N/A

0DataRank · unranked

0 citations

Colin A. Ellis, Kevin Xie, Nishant Sinha, Sharon X. Xie, Kathryn A. Davis +8 more

Further delineating bevacizumab's response spectrum

Nature Reviews Clinical Oncology(2014)10.1038/nrclinonc.2014.61

N/A

0DataRank · unranked

0 citations

Patrick Y. Wen, David A. Reardon

Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae615

N/A

0DataRank · unranked

8 citations

Jacobo Buelvas Mebarak, John C Magnotto, George A. Stamatiades, Yanan Kuang, Cloud P. Paweletz +13 more

OTME-8. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab070.059

N/A

0DataRank · unranked

0 citations

Orr Ashenberg, Elizabeth Perez, Sascha Marx, Prisca Liberali, Nathan D. Mathewson +5 more

PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1135

N/A

0DataRank · unranked

126 citations

David A. Reardon, Michael Weller, John H. Sampson, Mustafa Khasraw

Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus

Molecular Cell(2020)10.1016/j.molcel.2020.05.015

N/A

0DataRank · unranked

69 citations

Shawn M. Lyons, Mykola Zdioruk, Niklas von Spreckelsen, Rubén Ferrer-Luna, Hirotaka Ito +18 more

Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy

Neuro-Oncology(2020)10.1093/neuonc/noaa154

N/A

0DataRank · unranked

57 citations

Timothy F. Cloughesy, Marcela V. Maus, Robert M. Prins, David A. Reardon, Adam M. Sonabend +1 more

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

Neuro-Oncology(2020)10.1093/neuonc/noaa015

N/A

0DataRank · unranked

41 citations

Michael Weller, Joohee Sul, Stephen Bagley, Solmaz Sahebjam, Martin J. van den Bent +19 more

Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma

JAMA Oncology(2020)10.1001/jamaoncol.2020.4937

N/A

0DataRank · unranked

29 citations

Ugonma Chukwueke, Timothy R. Smith, Keith L. Ligon, Ayal A. Aizer, David A. Reardon +2 more

Short-term outcomes associated with temozolomide vs. PCV chemotherapy for 1p/19q-codeleted WHO grade III anaplastic oligodendrogliomas: a national evaluation

medRxiv(2020)10.1101/2020.03.29.20046805

N/A

0DataRank · unranked

0 citations

Malia McAvoy, Vasileios K. Kavouridis, Timothy R. Smith, Mehdi Touat, David A. Reardon +2 more

Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: Report of a case imaged serially by MRA over four years

UNC Libraries(2020)10.17615/56qd-8e92

N/A

0DataRank · unranked

0 citations

Elizabeth Bullitt, David A. Reardon, Stephen Aylward, James J. Vredenburgh, Allan H. Friedman +4 more

A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MR

UNC Libraries(2020)10.17615/sjyh-p364

N/A

0DataRank · unranked

0 citations

J. Keith Smith, David A. Reardon, Elizabeth Bullitt

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002459

N/A

0DataRank · unranked

83 citations

Stephen Bagley, Patrick Y. Wen, Michael Lim, Michael Platten, Howard Colman +16 more

Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making

Neuro-Oncology(2021)10.1093/neuonc/noab282

N/A

0DataRank · unranked

30 citations

Gilbert C Youssef, Mehdi Touat, J. Bryan Iorgulescu, Sydney Whorral, Marie Allen +17 more

Improved outcomes associated with maximal extent of resection for butterfly glioblastoma: insights from institutional and national data

Acta Neurochirurgica(2021)10.1007/s00701-021-04844-w

N/A

0DataRank · unranked

21 citations

Vasileios K. Kavouridis, Francesca Siddi, Elisabetta Mezzalira, Maya Harary, J. Bryan Iorgulescu +3 more

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy

Frontiers in Oncology(2021)10.3389/fonc.2021.679331

N/A

0DataRank · unranked

13 citations

Mary Jane Lim-Fat, Lei Qin, Angie Li, Annie G. Bryant, Camden Bay +8 more

Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4064

N/A

0DataRank · unranked

44 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma

American Journal of Neuroradiology(2022)10.3174/ajnr.a7488

N/A

0DataRank · unranked

36 citations

Elizabeth Flagg, Ken Chang, Harrison X. Bai, Hugo J.W.L. Aerts, Martin Vallières +3 more

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.28.497997

N/A

0DataRank · unranked

0 citations

Sampurna Chatterjee, Elizabeth M. Perez, Simon Gritsch, Sylvie Roberge, Mark Duquette +19 more

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity

Science Translational Medicine(2023)10.1126/scitranslmed.abo4778

N/A

0DataRank · unranked

74 citations

Clemens Reinshagen, Thijs van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca +6 more

Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3714

N/A

0DataRank · unranked

52 citations

J. Bryan Iorgulescu, Alexander Ling, Genaro R. Villa, Josephina A.M.A. Gadet, Laxmi Parida +6 more

Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?

Neuro-Oncology(2023)10.1093/neuonc/noad211

N/A

0DataRank · unranked

36 citations

Alexander Ling, David A. Reardon, E. Antonio Chiocca, Ethan Chen

Investigative needle core biopsies for multi-omics in Glioblastoma

medRxiv(2023)10.1101/2023.12.29.23300541

N/A

0DataRank · unranked

6 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +44 more

Glioma genetic profiles associated with electrophysiologic hyperexcitability

medRxiv(2023)10.1101/2023.02.22.23285841

N/A

0DataRank · unranked

2 citations

Maria Kristina Dorotan, Hia S. Ghosh, Emily Lapinskas, Jayne Vogelzang, David A. Reardon +5 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395.v1

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Data from Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

(2023)10.1158/1078-0432.c.6516909

N/A

0DataRank · unranked

0 citations

David A. Reardon, James E. Herndon, Jennifer Marcello, Jennifer A. Quinn, Jeremy N. Rich +9 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168.v1

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastoma

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.06.036

N/A

0DataRank · unranked

39 citations

Patrick Y. Wen, David A. Reardon, Stecia‐Marie Fletcher, Alexandra J. Golby, Nathan McDannold

Non-Invasive Blood-Brain Barrier Disruption Using Acoustic Holography With a Clinical Focused Ultrasound System

IEEE Transactions on Biomedical Engineering(2024)10.1109/tbme.2024.3407678

N/A

0DataRank · unranked

12 citations

Yongzhi Zhang, Stecia‐Marie Fletcher, Patrick Y. Wen, David A. Reardon, Alexandra J. Golby +2 more

David A. Reardon

Indexed papers

Top data-sharing exemplar

Papers